Product Information

RELPAX 20 MG TABLET is a brand product labeled by Roerig, priced at $77.4338 per EA under NDC 00049233045. Its NADAC has been published 530 times since Nov 28, 2013.

FDA first approved this application on Dec 26, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RELPAX 20 MG TABLET

eletriptan hydrobromide
$77.4338per EA
Discontinued

Strength

20 mg/1

Manufacturer

Roerig

NDC

00049233045

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ELETRIPTAN HYDROBROMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA021016

FDA Approved

12/26/2002

TE Code

AB

On Market Since

12/26/2002

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for RELPAX 20 MG TABLET has been published 530 times since Nov 28, 2013, and over the history we have for it it has risen 155.0%. The table below summarizes its recorded NADAC range and movement.

Current price$77.4338 per EA
All-time high$78.1117 (Jul 15, 2026)
All-time low$30.3679 (Nov 28, 2013)
52-week high$78.1117
52-week low$77.1903
Median price$59.5110
Average price$56.3822
Largest weekly change+18.3% (Aug 21, 2024)
Weeks tracked530
Tracking sinceNov 28, 2013

Price History

1W

+0.0%

1M

+0.0%

3M

+0.3%

6M

+0.0%

1Y

-0.2%

3Y

+18.0%

5Y

+18.0%

All

+155.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RELPAX 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RELPAX 20 MG TABLET, manufactured by Roerig, is $77.4338 per EA (NDC 00049233045), effective Aug 19, 2026.

How has the price of RELPAX 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for RELPAX 20 MG TABLET has risen 155.0%. It has been tracked across 530 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RELPAX 20 MG TABLET?

Since Nov 28, 2013, the NADAC for RELPAX 20 MG TABLET has ranged from a low of $30.3679 (Nov 28, 2013) to a high of $78.1117 (Jul 15, 2026), with a median of $59.5110 per EA.

Are there cheaper alternatives to RELPAX 20 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ELETRIPTAN HBR 20 MG TABLET, is $1.9354 per EA — about 98% below RELPAX 20 MG TABLET.

Who manufactures RELPAX 20 MG TABLET?

RELPAX 20 MG TABLET (NDC 00049233045) is labeled by Roerig, and CMS classifies it as a brand product.